DRAFT PHARMACEUTICAL DEVELOPMENT FOR …
Working document QAS/08.251 January 2008 RESTRICTED DRAFT PHARMACEUTICAL DEVELOPMENT FOR MULTISOURCE (GENERIC) PHARMACEUTICAL PRODUCTS This draft is based on the concept paper QSM/EC/07.29 “Guideline for pharmaceutical
Download DRAFT PHARMACEUTICAL DEVELOPMENT FOR …
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
FDA/PQRI Conference on Advancing Product Quality
pqri.orgBiopharmaceutics Classification System • BCS is a scientific framework for classifying drug substances based on their aqueous solubility and intestinal
Excipients and information for the package leaflet EN
www.ema.europa.eu9 October 2017 EMA/CHMP/302620/2017 Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668)
Medicines Control Council : General Information
www.kznhealth.gov.zaRegistration of Medicines General Information 2.01 General information Feb08 v4.doc April 2008 Page1 of 48 MEDICINES CONTROL COUNCIL GENERAL INFORMATION
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines Pharmaceutical & Analytical 2.02 PA Jun11 v6 showing changes.doc Page June 2011 1 of 27 MEDICINES CONTROL COUNCIL PHARMACEUTICAL AND ANALYTICAL
GUIDELINE ON SUBMISSION OF …
www.pharmalytik.comWorking document QAS/10.373/Rev.1 page 6 173 174 1.5 Guidance on format 175 176 The recommendations outlined in the WHO general filing guideline Guideline on submission 177 of documentation for a multisource (generic) finished pharmaceutical product (FPP): 178 preparation of product dossiers (PDs) in common technical …
GUIDELINE ON SUBMISSION OF …
www.who.intWorking document QAS/10.375 page 5 116 an existing API is one that has been previously authorized through a finished product by a 117 stringent regulatory authority1.APIs from fermentation, biological, biotechnological or